Latest research news are now in your pocket

Saturday, 20 August 2016

World's first Leprosy vaccine in India goes on trial

Source: Pixabay

There is about 60% of the global leprosy patients live in India. So it is vital for Indians to come forward with a possible solution to eradicate leprosy events. As reported recently in Times of India News from Chennai the first exclusive vaccine made in India goes on trial. It will be piloted in districts of Bihar and Gujrat in few weeks.

The disease that made 1.25 lack people cripple every year in India so the vaccine should be an important subject to be put forward in trials. If the pilot phase turns out to be satisfactory then the programme will be implicated across the country.

The vaccine mycobacterium indicus pranii or MIP will be administered to people in close contact or subjected to infection by the bacteria. "It is the first vaccine for leprosy, and India will be the first to have a large-scale vaccination programme. Trials have shown that if the vaccine is given to people in close contact with the affected, cases can be brought down by 60% in three years. It expedites cure rate if given to people with skin lesions," said Indian Council of Medical Research director general Dr Soumya Swaminathan.

The Director of National Institute of Immunology, G.P. Talwar has developed this vaccine and also got approval from DCGI and US-FDA.


Share:

0 comments:

Post a Comment

Copyright © We The Microbiologist Research News | Powered by Blogger
Design by SimpleWpThemes | Blogger Theme by NewBloggerThemes.com